Author:
Schneider Christian K.,Schäffner-Dallmann Gabriele
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference20 articles.
1. Reichert, J. M., Rosensweig, C. J., Faden, L. B. & Dewitz, M. C. Monoclonal antibody successes in the clinic. Nature Biotech. 23, 1073–1078 (2005).
2. Cavagnaro, J. A. Preclinical safety evaluation of biotechnology-derived pharmaceuticals. Nature Rev. Drug Discov. 1, 469–475 (2002).
3. Chapman, K., Pullen, N., Graham, M. & Ragan, I. Preclinical safety testing of monoclonal antibodies: the significance of species relevance. Nature Rev. Drug Discov. 6, 120–126 (2007).
4. Europeran Commision. Regulation (EC) 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Official Journal of the European Union 1, L 136/1–L 136/33 (2004).
5. European Medicines Agency (EMEA). Refusal Assessment Report for Alpheon. EMEA web site [
online
], (2006).
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献